Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
DECEMBER 2022LIFE SCIENCES REVIEW6Laboratory technology is often at the forefront of medical advances, featuring a wide range and complexity of tests and services. This growth is expected to continue in the coming years. The advancement of laboratory technology, which includes new tests as well as improving equipment and testing techniques, has enabled labs to conduct their testing more efficiently and automatically. The healthcare industry welcomes innovation, especially when it improves efficiency over existing methods and clinical laboratory technicians are likely to play a more prominent role in healthcare delivery.Currently, the clinical laboratory services in Europe register a CAGR of 6.38 per cent. Increasing occurrences of infectious diseases and the need for early and accurate diagnosis along with advances in clinical diagnosis methods explain this growth. Moreover, increased adoption of digital pathology platforms and preference for comprehensive health check-ups are expected to contribute significantly to the growth of the European clinical laboratory services market in the future.In this edition of Life Sciences Review Europe, we present the top ten Clinical Laboratory Services Companies in Europe - 2022 and the top five Clinical Laboratory Service Companies in the UK - 2022 that are leading the development of the healthcare industry with innovation. Medical Diagnosis, Labor Berlin, NADMED, and PeploBio are companies that create a link between science and the healthcare industry. We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs ­ Dr Sarah Tregenza PhD BSc (Hons), APAC Oncology Medical Affairs Director, Pierre Fabre & Dr Kim M. Bonner, BSc (Hons) VMD PhD, Executive Director, Clinical Development, Syneos Health presenting their ideas and opinions in developing high-quality laboratory diagnosis and services through comprehensive expertise and scientific excellence. We hope the valuable insights from industry thought leaders featured in this edition will guide you to make informed decisions for your organization.Let us know your thoughts!EDITORIALInnovation Propels Clinical Testing into a New EraCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsDecember - 02 - 2022, Vol 03, Issue - 05 (ISSN 2831-8323) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com VisualizersRonald DonovanVictor Cruz Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com
< Page 5 | Page 7 >